Hepion Pharmaceuticals (HEPA) Short Interest Ratio & Short Volume $0.07 +0.01 (+18.81%) As of 06/13/2025 03:27 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Hepion Pharmaceuticals Short Interest DataHepion Pharmaceuticals (HEPA) has a short interest of 14,000 shares, representing 0.21% of the float (the number of shares available for trading by the public). This marks a -87.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.30 million shares to cover all short positions.Current Short Interest14,000 sharesPrevious Short Interest110,900 sharesChange Vs. Previous Month-87.38%Dollar Volume Sold Short$910.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares10,935,000 sharesShort Percent of Float0.21%Today's Trading Volume317,295 sharesAverage Trading Volume1,304,771 sharesToday's Volume Vs. Average24% Short Selling Hepion Pharmaceuticals? Sign up to receive the latest short interest report for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHEPA Short Interest Over TimeHEPA Days to Cover Over TimeHEPA Percentage of Float Shorted Over Time Hepion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202514,000 shares $910.00 -87.4%0.2%0 $0.07 5/15/2025110,900 shares $14.03 thousand -75.3%N/A0 $0.13 4/30/2025448,200 shares $129.71 thousand -30.8%4.1%0.1 $0.29 4/15/2025647,400 shares $226.59 thousand +224.0%5.9%0.2 $0.35 3/31/2025199,800 shares $85.89 thousand +25.2%26.1%0.1 $0.43 3/15/2025159,600 shares $183.54 thousand -96.2%14.9%0.2 $1.15 2/28/20254,160,000 shares $524.16 thousand -12.4%39.4%0.2 $0.13 2/15/20254,750,000 shares $869.73 thousand +75.3%44.9%0.3 $0.18 1/31/20252,710,000 shares $486.45 thousand +1,180.7%25.5%0.2 $0.18 1/15/2025211,600 shares $90.50 thousand +774.4%3.0%0 $0.43 Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202424,200 shares $11.38 thousand -44.8%0.4%0.4 $0.47 12/15/202443,800 shares $25.84 thousand -7.2%0.6%1 $0.59 11/30/202447,200 shares $31.53 thousand -26.6%0.7%1.1 $0.67 11/15/202464,300 shares $43.72 thousand -2.1%0.9%1.6 $0.68 10/31/202465,700 shares $42.64 thousand +247.6%1.1%1.5 $0.65 10/15/202418,900 shares $10.76 thousand -24.7%0.3%0.4 $0.57 9/30/202425,100 shares $16.82 thousand -59.9%0.4%0.2 $0.67 9/15/202462,600 shares $46.32 thousand -17.3%1.1%0.4 $0.74 8/31/202475,700 shares $63.44 thousand -6.8%1.3%0.5 $0.84 8/15/202481,200 shares $54.79 thousand -29.5%1.4%0.5 $0.67 7/31/2024115,200 shares $90.18 thousand +852.1%2.0%0.7 $0.78 7/15/202412,100 shares $12.83 thousand -50.4%0.2%0.1 $1.06 6/30/202424,400 shares $24.89 thousand +58.4%0.5%0.7 $1.02 6/15/202415,400 shares $17.08 thousand -40.1%0.3%0.4 $1.11 5/31/202425,700 shares $32.38 thousand -21.7%0.5%0.6 $1.26 5/15/202432,800 shares $38.05 thousand -48.7%0.6%0.7 $1.16 4/30/202463,900 shares $87.22 thousand -0.2%1.2%0.9 $1.37 4/15/202464,000 shares $139.52 thousand +1.9%1.2%0.8 $2.18 3/31/202462,800 shares $156.37 thousand +11.0%1.5%0.8 $2.49 3/15/202456,600 shares $127.92 thousand -19.6%1.3%0.7 $2.26 2/29/202470,400 shares $209.09 thousand -11.0%1.6%0.8 $2.97 2/15/202479,100 shares $211.99 thousand +18.2%1.9%0.9 $2.68 1/31/202466,900 shares $127.11 thousand -17.7%1.6%0.9 $1.90 1/15/202481,300 shares $223.58 thousand -18.0%1.9%1.2 $2.75 12/31/202399,200 shares $321.41 thousand -18.5%2.3%1.5 $3.24 12/15/2023121,700 shares $484.37 thousand -61.6%2.8%1.9 $3.98 11/30/2023317,200 shares $1.02 million -4.4%7.4%5.7 $3.22 11/15/2023331,700 shares $959.01 thousand +15.0%7.8%6.8 $2.89 10/31/2023288,500 shares $1.35 million -22.8%6.9%8.8 $4.67 10/15/2023373,700 shares $1.72 million -11.4%9.9%12.3 $4.61Collect $7k per month from Tesla’s SECRET dividend (Ad)I just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend. It’s a legal income shortcut tied to Tesla and other tech giants. This backdoor is already live—and it could change the way you earn.Start your monthly payout stream today 9/30/2023421,900 shares $2.11 million +10.5%11.2%15.7 $4.99 9/15/2023381,700 shares $2.00 million +24.9%10.1%13.3 $5.25 8/31/2023305,700 shares $2.28 million +3.1%8.0%8.9 $7.45 8/15/2023296,600 shares $2.07 million -8.9%7.7%0.8 $6.99 7/31/2023325,700 shares $2.59 million +2.4%8.6%0.9 $7.95 7/15/2023318,000 shares $3.18 million -1.8%8.4%0.9 $9.99 6/30/2023323,800 shares $3.40 million -11.1%8.5%0.9 $10.50 6/15/2023364,100 shares $4.21 million +52.9%9.6%1 $11.57 5/31/2023238,200 shares $2.29 million +237.4%6.3%0.7 $9.60 5/15/202370,600 shares $473.02 thousand +105.8%1.9%0.2 $6.70 4/30/2023685,900 shares $477.04 thousand +6.3%0.9%3.8 $0.70 4/15/2023645,100 shares $490.28 thousand -7.7%0.9%2.6 $0.76 3/31/2023698,800 shares $542.62 thousand -2.8%0.9%1 $0.78 3/15/2023719,000 shares $540.33 thousand +0.3%0.9%1 $0.75 2/28/2023716,600 shares $625.95 thousand -13.8%0.9%1 $0.87 2/15/2023831,100 shares $706.44 thousand -8.3%1.1%1.1 $0.85 1/31/2023905,900 shares $661.13 thousand -49.1%1.2%1.2 $0.73 1/15/20231,780,000 shares $1.65 million +221.0%2.3%2.5 $0.93 12/30/2022554,600 shares $166.55 thousand +0.3%0.7%1.7 $0.30 12/15/2022553,100 shares $182.52 thousand +3.2%0.7%2.6 $0.33 11/30/2022535,800 shares $195.67 thousand -2.5%0.7%2.9 $0.37 11/15/2022549,700 shares $241.81 thousand -5.4%0.7%3.2 $0.44 10/31/2022581,200 shares $309.49 thousand -9.9%0.8%3.9 $0.53 10/15/2022645,200 shares $296.73 thousand -6.6%0.9%4.7 $0.46 9/30/2022691,000 shares $349.09 thousand -6.3%0.9%4.9 $0.51 9/15/2022737,500 shares $441.03 thousand -9.5%1.0%5.1 $0.60 8/31/2022814,700 shares $556.20 thousand -15.3%1.1%5.2 $0.68 8/15/2022961,600 shares $712.83 thousand -12.6%1.3%5.9 $0.74 7/31/20221,100,000 shares $594 thousand +21.6%1.5%5.6 $0.54 7/15/2022904,700 shares $544.09 thousand -7.7%1.2%4.6 $0.60 6/30/2022980,300 shares $561.22 thousand -7.5%1.3%4.9 $0.57 6/15/20221,060,000 shares $717.62 thousand -7.0%1.4%4.6 $0.68 5/31/20221,140,000 shares $889.31 thousand -7.3%1.5%4.8 $0.78 5/15/20221,230,000 shares $852.39 thousand -14.6%1.6%4.1 $0.69 4/30/20221,440,000 shares $1.33 million -9.4%1.9%4.6 $0.93 4/15/20221,590,000 shares $1.67 million -7.0%2.1%4.3 $1.05 3/31/20221,710,000 shares $2.21 million +8.2%2.3%4.2 $1.29 3/15/20221,580,000 shares $1.69 million -0.6%2.1%3 $1.07 2/28/20221,590,000 shares $1.75 million -5.4%2.1%2.8 $1.10 2/15/20221,680,000 shares $1.71 million -10.2%2.2%2.7 $1.02 1/31/20221,870,000 shares $1.83 million +2.2%2.5%2.6 $0.98 1/15/20221,830,000 shares $2.12 million -6.2%2.4%2.4 $1.16 12/31/20211,950,000 shares $2.22 million +2.6%2.6%2.6 $1.14 12/15/20211,900,000 shares $2.30 million +15.2%2.5%2.4 $1.21 11/30/20211,650,000 shares $2.05 million -7.8%2.2%1.5 $1.24 11/15/20211,790,000 shares $2.63 million -1.1%2.4%1.5 $1.47 10/29/20211,810,000 shares $2.59 million -11.3%2.4%1.5 $1.43 10/15/20212,040,000 shares $3.10 million +17.9%2.7%1.6 $1.52 9/30/20211,730,000 shares $2.65 million -40.1%2.3%1.1 $1.53 9/15/20212,890,000 shares $4.60 million +61.5%3.8%1.7 $1.59Collect $7k per month from Tesla’s SECRET dividend (Ad)I just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend. It’s a legal income shortcut tied to Tesla and other tech giants. This backdoor is already live—and it could change the way you earn.Start your monthly payout stream today 8/31/20211,790,000 shares $2.88 million -10.5%2.4%0.9 $1.61 8/13/20212,000,000 shares $2.94 million -14.5%2.6%1.1 $1.47 7/30/20212,340,000 shares $3.60 million -2.1%3.1%1.2 $1.54 7/15/20212,390,000 shares $3.80 million +64.8%3.1%1.1 $1.59 6/30/20211,450,000 shares $2.87 million -13.7%1.9%0.7 $1.98 6/15/20211,680,000 shares $3.70 million +27.3%2.2%0.8 $2.20 5/28/20211,320,000 shares $2.24 million +6.5%1.7%0.4 $1.70 5/14/20211,240,000 shares $1.93 million -32.6%N/A0.3 $1.56 4/30/20211,840,000 shares $3.28 million -20.7%N/A0.3 $1.78 4/15/20212,320,000 shares $4.08 million -22.9%N/A0.4 $1.76 3/31/20213,010,000 shares $5.36 million +57.6%N/A0.5 $1.78 3/15/20211,910,000 shares $4.66 million -26.5%N/A0.3 $2.44 2/26/20212,600,000 shares $5.10 million +273.3%N/A0.5 $1.96 2/12/2021696,500 shares $1.98 million +159.7%N/A0.1 $2.84 1/29/2021268,200 shares $549.81 thousand -6.8%N/A0.1 $2.05 1/15/2021287,600 shares $672.98 thousand -58.0%N/A0.1 $2.34 12/31/2020685,100 shares $1.61 million +236.7%N/A0.4 $2.35 12/15/2020203,500 shares $386.65 thousand -43.4%N/A0.1 $1.90 11/30/2020359,500 shares $607.56 thousand +9.7%N/A0.4 $1.69 11/15/2020327,600 shares $956.59 thousand +51.3%N/A1.5 $2.92 10/30/2020216,600 shares $723.44 thousand -39.7%N/A0.9 $3.34 10/15/2020359,400 shares $1.25 million -26.7%N/A0.9 $3.47 9/30/2020490,500 shares $1.53 million +4.1%N/A0.9 $3.11 9/15/2020471,000 shares $1.53 million -22.7%N/A0.3 $3.25 HEPA Short Interest - Frequently Asked Questions What is Hepion Pharmaceuticals' current short interest? Short interest is the volume of Hepion Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 14,000 shares of HEPA short. 0.21% of Hepion Pharmaceuticals' shares are currently sold short. Learn More on Hepion Pharmaceuticals' current short interest. What is a good short interest percentage for Hepion Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Hepion Pharmaceuticals' floating shares are currently sold short. Is Hepion Pharmaceuticals' short interest increasing or decreasing? Hepion Pharmaceuticals saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 14,000 shares, a drop of 87.4% from the previous total of 110,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hepion Pharmaceuticals' short interest compare to its competitors? 0.21% of Hepion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Hepion Pharmaceuticals: Qualigen Therapeutics, Inc. (4.32%), Galmed Pharmaceuticals Ltd. (8.60%), Entero Therapeutics, Inc. (26.55%), Spruce Biosciences, Inc. (0.08%), Scinai Immunotherapeutics Ltd. (0.15%), Aspira Women's Health Inc. (1.19%), Vaccinex, Inc. (0.17%), Protagenic Therapeutics, Inc. (5.97%), Akanda Corp. (0.70%), Conduit Pharmaceuticals Inc. (7.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Hepion Pharmaceuticals stock? Short selling HEPA is an investing strategy that aims to generate trading profit from Hepion Pharmaceuticals as its price is falling. HEPA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hepion Pharmaceuticals? A short squeeze for Hepion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HEPA, which in turn drives the price of the stock up even further. How often is Hepion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEPA, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies QLGN Short Interest Data GLMD Short Interest Data ENTO Short Interest Data SPRB Short Interest Data SCNI Short Interest Data AWH Short Interest Data VCNX Short Interest Data PTIX Short Interest Data AKAN Short Interest Data CDT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HEPA) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HEPA Stock Free HEPA Stock Alerts